Clinical Roundup Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers April 04, 2025Vol.51 No.13
Clinical Roundup Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds April 04, 2025Vol.51 No.13
Clinical Roundup Even light daily physical activity linked to lower cancer risk, NIH and Oxford study shows March 28, 2025Vol.51 No.12
Clinical Roundup Study reinforces Tagrisso as the backbone therapy for EGFR-mutated lung cancer March 28, 2025Vol.51 No.12
Clinical Roundup Pandemic caused temporary disruptions in CRC screening and minimal impact on diagnosis, two studies show March 28, 2025Vol.51 No.12
Clinical Roundup Investigational Orca-T treatment for hematologic malignancies meets primary endpoint in phase III trial March 28, 2025Vol.51 No.12
Clinical Roundup UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma March 28, 2025Vol.51 No.12
Clinical Roundup Mutated cells can persist for years without becoming cancer and need an inflammatory “push” for malignancy to occur, COH study shows March 28, 2025Vol.51 No.12
Clinical Roundup AI tool helps predict who will benefit from focal therapy for prostate cancer, study shows March 21, 2025Vol.51 No.11
Clinical Roundup Shorter radiation treatment approach shows safety and efficacy for early-stage prostate cancer March 21, 2025Vol.51 No.11
